These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 1850357)

  • 21. Cholecystokinin-octapeptide stimulates hypothalamic-pituitary-adrenal function in rats: role of corticotropin-releasing hormone.
    Kamilaris TC; Johnson EO; Calogero AE; Kalogeras KT; Bernardini R; Chrousos GP; Gold PW
    Endocrinology; 1992 Apr; 130(4):1764-74. PubMed ID: 1312423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of subcutaneous and intranasal administration of ovine corticotropin-releasing hormone in man: comparison with intravenous administration.
    DeBold CR; Sheldon WR; DeCherney GS; Jackson RV; Nicholson WE; Island DP; Orth DN
    J Clin Endocrinol Metab; 1985 May; 60(5):836-40. PubMed ID: 2984233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism.
    Calogero AE; Kamilaris TC; Gomez MT; Johnson EO; Tartaglia ME; Gold PW; Chrousos GP
    Endocrinology; 1989 Nov; 125(5):2445-53. PubMed ID: 2551652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The hypothalamic-pituitary-adrenal axis response to ovine corticotropin-releasing-hormone stimulation tests in healthy and hospitalized foals.
    Johnson K; Peterson J; Kopper J; Dembek K
    J Vet Intern Med; 2023 Jan; 37(1):292-301. PubMed ID: 36651191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ovine corticotropin-releasing hormone (CRH) stimulation test is superior to the human CRH stimulation test for the diagnosis of Cushing's disease.
    Nieman LK; Cutler GB; Oldfield EH; Loriaux DL; Chrousos GP
    J Clin Endocrinol Metab; 1989 Jul; 69(1):165-9. PubMed ID: 2543689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response to corticotropin-releasing hormone during pregnancy in the baboon.
    Goland RS; Stark RI; Wardlaw SL
    J Clin Endocrinol Metab; 1990 Apr; 70(4):925-9. PubMed ID: 2156891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of the hypothalamic-pituitary-adrenal axis during water deprivation.
    Aguilera G; Lightman SL; Kiss A
    Endocrinology; 1993 Jan; 132(1):241-8. PubMed ID: 8380375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
    van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
    Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of synthetic ovine corticotropin-releasing hormone on plasma concentrations of immunoreactive adrenocorticotropin, alpha-melanocyte-stimulating hormone, and cortisol in dogs with naturally acquired adrenocortical insufficiency.
    Peterson ME; Kemppainen RJ; Orth DN
    Am J Vet Res; 1992 Mar; 53(3):421-5. PubMed ID: 1317690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pituitary and adrenocortical responses to the ovine corticotropin releasing hormone in depressed patients and healthy volunteers.
    Amsterdam JD; Maislin G; Winokur A; Kling M; Gold P
    Arch Gen Psychiatry; 1987 Sep; 44(9):775-81. PubMed ID: 2820340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovine corticotropin-releasing hormone stimulation test in patients with chronic renal failure: pharmacokinetic properties, and plasma adrenocorticotropic hormone and serum cortisol responses.
    Siamopoulos KC; Eleftheriades EG; Pappas M; Sferopoulos G; Tsolas O
    Horm Res; 1988; 30(1):17-21. PubMed ID: 2851525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of experimentally induced hyperthyroidism on central hypothalamic-pituitary-adrenal axis function in rats: in vitro and in situ studies.
    Johnson EO; Calogero AE; Konstandi M; Kamilaris TC; La Vignera S; Chrousos GP
    Pituitary; 2013 Jun; 16(2):275-86. PubMed ID: 22975847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiological role of corticotropin-releasing factor in the control of adrenocorticotropin-mediated corticosterone release from the rat adrenal gland.
    van Oers JW; Hinson JP; Binnekade R; Tilders FJ
    Endocrinology; 1992 Jan; 130(1):282-8. PubMed ID: 1309333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of repetitive administration of recombinant human interleukin-1 beta, an analog or corticotropin-releasing hormone combined with lysine vasopressin on rats with glucocorticoid-induced secondary adrenocortical insufficiency.
    Murakami N; Fukata J; Usui T; Naito Y; Tominaga T; Nakai Y; Masui Y; Nakao K; Imura H
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1344-8. PubMed ID: 1312168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Congenital absence of vasopressin and age-dependent changes in ACTH and corticosterone stress responses in rats.
    Zelena D; Barna I; Pintér O; Klausz B; Varga J; Makara GB
    Stress; 2011 Jul; 14(4):420-30. PubMed ID: 21438769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control of the hypothalamo-pituitary-adrenal axis in the neonatal period: adrenocorticotropin and corticosterone stress responses dissociate in vasopressin-deficient brattleboro rats.
    Zelena D; Domokos A; Barna I; Mergl Z; Haller J; Makara GB
    Endocrinology; 2008 May; 149(5):2576-83. PubMed ID: 18276753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corticotropin-releasing hormone and the sympathoadrenal system are major mediators in the effects of peripherally administered exendin-4 on the hypothalamic-pituitary-adrenal axis of male rats.
    Gil-Lozano M; Romaní-Pérez M; Outeiriño-Iglesias V; Vigo E; González-Matías LC; Brubaker PL; Mallo F
    Endocrinology; 2014 Jul; 155(7):2511-23. PubMed ID: 24731096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormalities in the hypothalamo-pituitary-adrenal axis in spontaneously hypertensive rats during development of hypertension.
    Hashimoto K; Makino S; Hirasawa R; Takao T; Sugawara M; Murakami K; Ono K; Ota Z
    Endocrinology; 1989 Sep; 125(3):1161-7. PubMed ID: 2547578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of the long-term administration of corticotropin-releasing factor on the pituitary-adrenal and pituitary-gonadal axis in the male rat.
    Rivier C; Vale W
    J Clin Invest; 1985 Feb; 75(2):689-94. PubMed ID: 2982917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.